Case report reveals recurrence-free survival in a pediatric prostatic rhabdomyosarcoma case treated with multimodal therapy, highlighting organ-preserving radiation strategies.
Context: The therapeutic transition from mutilating surgery to external radiotherapy followed by brachytherapy is increasingly effective in the treatment of rhabdomyosarcoma. Case presentation: 13-year-old child with no medical and surgical history, received for complete urine retention. Imaging examinations revealed a prostatic mass of 6 cm. The anatomopathological examination reveals an embryonic rhabdomyosarcoma. There was no recurrence after 3 years of follow-up after a multimodal treatment combining chemotherapy, external radiotherapy and high dose interstitial brachytherapy. Conclusion: Vesicoprostatic rhabdomyosarcomas in children are rare. The therapeutic strategy has evolved over the years owing to the technological advances in external radiotherapy and brachytherapy.
No takes yet. Share an insight, caveat, or question.
Ka et al. (2021) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: